SciELO - Scientific Electronic Library Online

 
vol.45 issue3Adult mesenchymal stem cell therapy for myelin repair in Multiple SclerosisIn Osteoporosis, differentiation of mesenchymal stem cells (MSCs) improves bone marrow adipogenesis author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Biological Research

Print version ISSN 0716-9760

Abstract

FIGUEROA, Fernando E; CARRION, Flavio; VILLANUEVA, Sandra  and  KHOURY, Maroun. Mesenchymal Stem Cell treatment for autoimmune diseases: a critical review. Biol. Res. [online]. 2012, vol.45, n.3, pp.269-277. ISSN 0716-9760.  http://dx.doi.org/10.4067/S0716-97602012000300008.

Mesenchymal stem cells (MSCs) are now known to display not only stem cell multipotency, but also robust antiinflammatory and regenerative properties. After widespread in-vitro and in-vivo preclinical testing, autologous and allogeneic MSCs have been applied in a range of immune mediated conditions, including graft versus host disease, Crohn's disease, multiple sclerosis, refractory systemic lupus erythematosus and systemic sclerosis. Current data suggests that MSCs may not only replace diseased tissues, but also exert several trophic, regenerative and antiinflammatory effects. While the clinical outcome in case reports and phase I-II trials seems occasionally striking, these limited results point to the need to perform controlled multicenter trials. Future advances from stem cell science can be expected to pinpoint significant MSC subpopulations and/or stem cell markers for improved regenerative or immunoregulatory properties.

Keywords : Mesenchymal stem cells; autoimmune diseases; cellular therapy.

        · text in English     · English ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License